Clinican BEAD-T1D: Building the Evidence to Address Disengagement in Type 1 Diabetes

Stanford University

Status: Withdrawn

Conditions: Type 1 Diabetes (T1D)

Treatments: Behavioral: Intervention to increase diabetes technology prescriptions

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT07491471

65313P

K23DK131342 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Youth with public insurance underutilize diabetes care, particularly diabetes technology which is associated with improvement in diabetes-specific outcomes. Thus, we urgently need studies to understand and increase diabetes technology utilization. This proposed research will (1) address the gap in knowledge of barriers and promoters in youth working with clinicians to identify and address factors associated with diabetes technology uptake and utilization.

Full description

As diabetes technologies have become more innovative and effective in the management of pediatric type 1 diabetes (T1D), research and usage has not engaged all youth living with T1D . Studies have consistently demonstrated lower rates of diabetes technology use in some youth. Although diabetes technology has the potential to improve in pediatric T1D outcomes. This proposal aims to build an evidence base for data-driven interventions designed to increase uptake and utilization of diabetes innovations by addressing barriers and supporting promoters of diabetes technology use. Focusing on clinicians, the overall objective of this proposal is to test a brief pilot intervention to increase provider recommendation of diabetes technology.

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• age 18+ years, providers who care for youth with T1D for at least 50% of their clinical efforts, practicing in the United States, care for youth with public insurance, health care role of physicians, advanced practice providers, or certified diabetes care & education specialists, and understand and willingness to follow study protocol.

Exclusion criteria

• significant cognitive impairment or medical or psychiatric condition that would interfere with participation in the study or lack of access to a smartphone or Wi-Fi via computer.

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

Pilot Intervention

Experimental group

Description:

The design for this phase is a prospective pilot study. The intervention will be delivered weekly over a four-week period and will include pre- and post-intervention assessments of survey measurements. The investigators will evaluate rates of diabetes technology utilization. Virtual delivery of the pilot intervention will facilitate national recruitment.

Treatment:

Behavioral: Intervention to increase diabetes technology prescriptions